{
    "Trade/Device Name(s)": [
        "ARCHITECT\u00ae SHBG",
        "ARCHITECT\u00ae SHBG Calibrators",
        "ARCHITECT\u00ae SHBG Controls"
    ],
    "Submitter Information": "Biokit S.A.",
    "510(k) Number": "K060818",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031717"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CDZ",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "December 20, 2006",
    "Summary Letter Received Date": "December 26, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1680",
        "21CFR862.1150",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Testosterone test system",
        "Calibrator, Secondary",
        "Single (Specified) Analyte Controls (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Sex hormone binding globulin (SHBG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium Heparin tube",
        "Sodium Heparin tube",
        "Ammonium Heparin tube",
        "Potassium EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT / System",
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Two-step direct sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT SHBG assay, calibrators, and controls for quantitative determination of sex hormone binding globulin in human serum and plasma using CMIA on ARCHITECT platforms.",
    "Indications for Use Summary": "Quantitative determination of sex hormone binding globulin (SHBG) in human serum and plasma to aid in the diagnosis of androgen disorders; calibrators for calibration and controls for accuracy verification of ARCHITECT system assays.",
    "fda_folder": "Clinical Chemistry"
}